Fermenta Biotech, a company in the Pharmaceuticals industry, reported revenue of ₹133 crore and net profit of ₹9.44 crore for the September 2026 quarter.
Fermenta Biotech (NSE: FERMENTA) closed at ₹446.15 on 20 Nov 2026. Its market capitalisation is ₹1,313 crore and it trades at 28.3 times earnings.
Incorporated in 1951, Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.